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Abstract 
Review on ING3, with data on DNA/RNA, on the 
protein encoded and where the gene is implicated. 
Identity 
Other names: Eaf4, ING2, MEAF4, p47ING3 
HGNC (Hugo): ING3 
Location: 7q31.31 
DNA/RNA 
Description 
In 1996, Karl Riabowol's group identified a new 
Tumor Suppressor Gene (TSG) by using subtractive 
hybridization between cDNAs from normal 
mammary epithelial cells and mammary epithelial 
cells from tumor. This experiment was followed by 
an in vivo screen for tumourigenesis. Using this 
method, the authors identified a new candidate TSG 
that they named ING1 for INhibitor of Growth 1 
(Garkavtsev et al., 1996). Few years later, ING2, 
ING3, ING4 and ING5 were identified by homology 
search. ING3 was identified through bioinformatic 
analyses in order to find human EST clone showing 
a high homology with the p33ING1b and p33ING2 
cDNAs (Nagashima et al., 2003). 
Figure 1. Chromosomal localization of the ING3 gene in 
Homo sapiens. 
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Figure 2. Structure and transcripts of Human ING3 genes. Coding regions are in dark blue and non-coding regions are 
represented in light blue. 
 
 
Transcription 
The ING3 gene has been mapped to chromosome 7 
at locus 7q31. Interestingly, unlike ING1, 2, 4 and 5, 
ING3 is located far from telomeric regions and is 
evolutionarily distinct from the other (Fig.1) (He et 
al., 2005). Human ING3 is made of twelve exons, 
resulting in 2 transcribed variants (ING3v1a, 
ING3v3) (Fig.2). 
Pseudogene 
INGX is the pseudogene of ING (He et al., 2005). 
Protein 
Description 
The ING proteins are characterized by the presence 
of a highly conserved PHD in their C-terminal part. 
This domain is commonly found in proteins involved 
in chromatin modification (Bienz, 2006; Mellor, 
2006). The C-terminal part of ING3 isoform contains 
a Leucine Zipper-Like domain (LZL) and a Novel 
Conserved Region (NCR) (Fig.3). 
Expression 
ING3 is ubiquitously expressed in mammalian  
tissues. Moreover, ING3 expression is increased in 
oocytes from Human, Rhesus monkey and mice 
(Awe and Byrne, 2013). 
Localisation 
ING3 contains an NLS domain, so it is mainly  
 
 
located in the nucleus. 
Function 
ING3 is a candidate tumor suppressor gene. ING3 
regulates apoptosis in a p53 dependent and 
independent manner.  
Indeed, ING3 activates bax transcription through 
p53 and promotes apoptosis via Fas/caspase 8 
pathway in melanoma cells (Nagashima et al., 2003; 
Wang and Li, 2006).  
Moreover, ING3 is a member of the human NuA4 
histone acetyltransferase (HAT) complex which is 
involved in transcriptional activation of genes 
through acetylation of histones H4 and H2A (Doyon 
et al., 2004).  
ING3 through its involvement in the NuA4 HAT 
complex regulates the expression of mTOR. 
Consequently, ING3 regulates oocyte polarization 
and asymmetric division during oocyte mice 
maturation through the mTOR pathway (Suzuki et 
al., 2013). 
Implicated in 
Ameloblastoma 
The analysis of LOH (loss of heterozygosity) for 
ING genes family, in 33 samples of ameloblastoma 
cases, showed a high percentage of allelic loss 
(48.5%) for ING3 gene.  
Moreover, there is a strong correlation between the 
inactivation of ING3 gene and tumor aggressiveness 
(Borkosky et al., 2010). 
 
 
Figure 3. Schematic representation of ING3 proteins structure. In the C-terminal part: Nuclear Localization Signal (NLS), 
Plant Homeo Domain (PHD). In the N-terminal part: Leucine Zipper-Like domain (LZL), Novel Conserved Region (NCR). 
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Breast cancer 
The analysis of ING3 status in 9 breast cancer cell 
lines revealed a downregulation of ING3v1 and v3 
mRNA in 2 of these cell lines. However, their 
mRNA abundances were increased in seven other 
cell lines compared to normal breast epithelial cells 
(Walzak et al., 2008). 
Colorectal carcinoma 
In colorectal carcinoma, the ING3 mRNA 
expression was reduced compared to colorectal non-
neoplastic mucosa (NNM). In addition, the 
expression of ING3 protein has been detected in the 
cytoplasm but not in the nucleus. Moreover, there is 
no difference of ING3 protein level between NNM 
and carcinomas tissues. However, the expression of 
ING3 was not correlated to the prognosis of patients 
with colorectal cancer. These results suggest that 
downregulation of ING3 may have a significant role 
in colorectal carcinogenesis (Gou et al., 2014). 
Cutaneous melanoma 
In malignant melanoma, nuclear expression of ING3 
was reduced compared to dysplastic nevi, while an 
increase of cytoplasmic expression is found, in 24%, 
39%, and 62% of the dysplastic nevi, primary 
melanoma, and metastases, respectively. In addition, 
the location of primary melanomas and the 
upregulated ING3 cytoplasmic expression are not 
correlated. In patients with strong nuclear ING3 
staining, the survival rate reached 93%, whereas in 
patients with negative-to-moderate nuclear ING3 
staining, the survival rate was just 44%. These 
findings suggest that ING3 is an important factor for 
melanoma prognosis and progression (Wang et al., 
2007). 
Head and neck squamous carcinoma 
The analysis of loss of heterozygosity in 49 head and 
neck squamous cell carcinoma (HNSCC) showed 
that 48% had an allelic deletion detected in 2 regions 
on chromosome 7q31 where ING3 is mapped. In 
addition, only one sample showed a missense 
mutation manifested by nucleotide change from 
GAC to GGC at codon 20 which leads to an amino 
acid substitution from aspartic acid to glycine. A 
silent mutation from GAC to GAT has been detected 
in three samples at codon 356 with no amino acid 
change. Moreover, 50% of primary tumor tissues 
and 75% of tumor derived cell lines showed a 
decreased expression of ING3 mRNA. In one case, a 
complete loss of ING3 mRNA has been detected in 
2 primary tissues. In this study, a significant decrease 
of ING3 mRNA expression but rare mutation found, 
suggests that a transcriptional mechanism, such as 
promoter methylation, may contribute to the 
HNSCC development (Gunduz et al., 2002). 
Hepatocellular carcinoma 
In the case of hepatocellular carcinoma (HCC), the 
analysis of ING3 mRNA expression revealed that in 
all the 49 tumor samples, ING3 was downregulated 
compared to normal livers. In addition, the 
expression of ING3 mRNA is reduced in 18 HCC 
cell lines compared to noncancerous cell lines. 
Moreover, in 64/112 samples of HCC, a 
downregulation of ING3 protein expression was 
found, while 24/112 samples had an upregulation of 
ING3 and 24/112 exhibited the same expression of 
ING3 protein. However, the overexpression of ING3 
suppresses cell proliferation in Hep3B cell line, thus 
confirming that ING3 may be tumor suppressor gene 
(Lu et al., 2012). Another study showed that 16/20 
patients with HCC exhibited a downregulation of 
ING3 protein and ING3 mRNA expression. In 
addition, in 4/6 hepatic cell lines, there is a 
downregulation of ING3 protein and ING3 mRNA 
expression (Yang et al., 2012). 
Lung cancer 
In two lung cancer cell lines, a downregulation of 
ING3v1 and v3 transcripts has been detected 
(Walzak et al., 2008). 
Ovarian cancer 
ING3v1 and ING3v3 showed a weak decrease of 
mRNA expression, in 1/1 ovarian cancer cell line GI-
102 (Walzak et al., 2008). 
Pancreatic cancer 
In GI-103 pancreatic cell line, mRNA expression of 
ING3v3 transcript is downregulated but, 
surprisingly, ING3v1 is upregulated (Walzak et al., 
2008). 
Prostate cancer 
In PC3 prostate cancer cell line, mRNA expression 
levels of ING3v1 and v3 are decreased (Walzak et 
al., 2008). 
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